# Homoarginine Supplementation in Patients After Stroke

> **NCT03692234** · NA · UNKNOWN · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 500 (estimated)

## Conditions studied

- Deficiency; Diet

## Interventions

- **DIETARY_SUPPLEMENT:** 125 mg L-homoarginine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03692234
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-22
- **Primary completion:** 2022-12
- **Final completion:** 2023-08
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03692234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03692234, "Homoarginine Supplementation in Patients After Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03692234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*